Related Experiment Video

Updated: Jul 4, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

TIP30 is associated with progression and metastasis of prostate cancer

Hui Zhang1, Yifen Zhang, Hai Ou Duan

  • 1Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

International Journal of Cancer
|June 6, 2008
PubMed

Insights

Tat-interacting protein 30 (TIP30) is overexpressed in metastatic prostate cancer. TIP30 promotes prostate cancer cell growth, metastasis, and androgen receptor transcription, suggesting it may drive disease progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Tat-interacting protein 30 (TIP30) exhibits tumor suppressor characteristics.
  • TIP30 gene deletion increases tumorigenesis in female mice.
  • Prostate cancer progression and metastasis are significant clinical challenges.

Purpose of the Study:

  • To investigate the role of TIP30 in prostate cancer progression and metastasis.
  • To analyze TIP30 gene expression in human prostate cancer databases.
  • To determine the functional impact of TIP30 on prostate cancer cell behavior.

Main Methods:

  • Analysis of DNA microarray databases for TIP30 expression in prostate cancer.
  • Immunohistochemical analysis of TIP30 nuclear expression in primary and metastatic prostate cancers.
  • Short hairpin RNA (shRNA)-mediated knockdown and ectopic overexpression of TIP30 in prostate cancer cell lines (PC3, LNCaP).
  • In vitro invasion assays and androgen receptor-mediated transcription assays.

Main Results:

  • TIP30 is overexpressed in metastatic prostate cancers.
  • Increased TIP30 nuclear expression correlates with prostate cancer progression and metastasis.
  • TIP30 knockdown suppresses prostate cancer cell growth and invasion.
  • TIP30 overexpression enhances prostate cancer cell invasion and androgen receptor transcription.

Conclusions:

  • TIP30 plays a significant role in prostate cancer progression.
  • TIP30 overexpression promotes prostate cancer cell growth and metastasis.
  • TIP30 may serve as a potential therapeutic target in prostate cancer.

More Related Videos

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...